Biomerics Acquires Dependable Plastics, Creates Medical Plastics DivisionBiomerics Acquires Dependable Plastics, Creates Medical Plastics Division
The Biomerics Interventional Medical Plastics Division integrates plastics processing expertise to enable rapid design, development, and manufacture of plastic components for the medical robotics and interventional markets.
July 11, 2022
Biomerics, a vertically integrated contract manufacturer serving the interventional medical device market, announced today the acquisition of Dependable Plastics and creation of the new Biomerics Interventional Medical Plastics (IMP) Division. With operations in Fairfield, CA, and Salt Lake City, Biomerics IMP is described as a full-service plastic component supplier to the interventional device market with a focus on robotic-assisted surgery.
Dependable Plastics was founded in 1983 by Harry Marquez and Emil Eger and is specialized in advanced thermoforming, liquid cast resin molding, and additive manufacturing. Combining these capabilities with Biomerics’ injection molding operations will position the new IMP division as a full-service plastic component supplier to the interventional markets. The acquisition marks Biomerics' second expansion into California, complementing its Micromachining Center of Excellence in Santa Clara, said the company in the news release.
Biomerics IMP has expertise in a variety of plastic component technologies including liquid cast resin, thermoforming, injection molding, and additive manufacturing. The division also offers secondary processes including pad printing, painting, shielding, and sub-assemblies. Biomerics provides design, development, and production services to help customers develop robot-assisted surgery systems.
Biomerics IMP will be led by Brett Poole, who will transfer responsibilities from the founders over the rest of the year. "I look forward to joining Biomerics to lead the Dependable Plastics team," said Poole, adding that his goal is to continue the company's "40-year history of excellence and integrating these new capabilities into Biomerics.”
"The Biomerics IMP Division was created to integrate Biomerics' various plastics manufacturing technologies to enable rapid design, development, and manufacture of plastic components for the robotic and interventional markets,” added Biomerics CEO Travis Sessions. “We look forward to partnering with our customers to make important advances in patient care."
Biomerics provides integrated engineering design and development, technology transfer, and contract manufacturing services through nine locations in the United States, Ireland, and Costa Rica. A supplier to 20 of the top 30 medical device OEMs, Biomerics provides interventional medical plastics, materials and compounding, injection molding, extrusion, micro machining of metals and polymers, laser processing, balloons and balloon catheters, advanced catheters, and image-guided-interventional technologies. The company is certified to ISO 13485:2016 and FDA registered.
You May Also Like